CIK 0000072444
- Accelerated filer
- Smaller reporting company
Vaxart, Inc.
Sign in to watch- Ticker
- VXRT
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 591212264
- Phone
- +1 650-550-3500
- Business address
- 310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
- Former names
- Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2010-11-22 | Aryeh Jason Director | Sale | −2,832 | $5.25 | $15K | 193,188 |
| 2010-11-19 | Aryeh Jason Director | Sale | −463 | $5.25 | $2K | 196,020 |
| 2010-11-18 | Aryeh Jason Director | Sale | −4,900 | $5.24 | $26K | 196,483 |
| 2010-11-11 | Aryeh Jason Director | Sale | −4,900 | $5.30 | $26K | 201,383 |
| 2010-11-10 | Aryeh Jason Director | Sale | −11,200 | $5.39 | $60K | 206,283 |
| 2010-11-09 | Aryeh Jason Director | Sale | −6,400 | $5.26 | $34K | 217,483 |
| 2010-10-20 | Aryeh Jason Director | Sale | −8,553 | $5.01 | $43K | 223,883 |
| 2010-10-18 | Aryeh Jason Director | Sale | −12,020 | $5.00 | $60K | 232,436 |
| 2010-10-11 | Aryeh Jason Director | Sale | −4,422 | $5.00 | $22K | 244,456 |
| 2010-07-26 | Kalnik Matthew W. SVP Strategic Plan. & Bus. Ops | Sale | −1,500 | $5.78 | $9K | 44,225.1 |
| 2010-07-19 | Kalnik Matthew W. SVP Strategic Plan. & Bus. Ops | Sale | −1,625 | $5.48 | $9K | 45,725.1 |
| 2010-06-11 | Aryeh Jason Director | Sale | −600 | $5.74 | $3K | 248,878 |
| 2010-06-11 | Aryeh Jason Director | Sale | −2,147 | $5.74 | $12K | 249,478 |
| 2010-06-03 | Aryeh Jason Director | Sale | −258 | $5.81 | $1K | 251,625 |
| 2010-05-31 | FAHIM RAAFAT E F President, CEO and CFO | Other acquisition | +3,096 | $4.20 | $13K | 333,733.94 |
| 2010-05-20 | Aryeh Jason Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2010-05-20 | LYNCH TIMOTHY P Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2010-05-20 | HARVEY RICHARD A JR Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2010-05-20 | DAVIS PETER B Director | Purchase | +3,816 | $5.24 | $20K | 14,630 |
| 2010-05-20 | DAVIS PETER B Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 |
Page 28 of 42 · 830 trades